 A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day. The post Why Bio-Rad Laboratories Rumored 10 Billion Qiagen Buyout Looks Unlikely appeared first on Investors Business Daily. 